VAERS Datenanalyse und Statistik
Zurueck zur Suche

Reporte zur Charge ZD3NZ

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

9Reporte angezeigt
0Todesfaelle
1Hospitalisiert
0Lebensbedrohlich
0Bleibende Schaeden
MI 3 NC 1 DC 1 PA 1 IL 1 WV 1 VA 1

VAERS 2400436

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge ZD3NZ

schwer
Staat
MI
Alter
49,0
Geschlecht
F
Eingang
03.08.2022
Impfdatum
18.11.2021
Beginn
19.07.2022
Tage bis Beginn
243,0
Dosis
N/A
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja
Angiogram pulmonary normal Anxiety disorder Blindness COVID-19 Chest X-ray normal Computerised tomogram head normal Electrocardiogram abnormal Electroencephalogram normal Impaired driving ability Magnetic resonance imaging head normal Respiratory tract congestion SARS-CoV-2 test positive Seizure Seizure like phenomena Sinus tachycardia Tremor Troponin normal Urinary incontinence

Symptomtext

Discharge Provider: MD Primary Care Provider: MD Admission Date: 7/19/2022 Discharge Date: Jul 21, 2022 PRESENTING PROBLEM: Seizure (HCC) Seizure-like activity (HCC) Anxiety disorder, unspecified type COVID-19 HOSPITAL COURSE: 50-year-old female history of type 2 diabetes, hypertension, psychiatric illness bipolar/schizophrenia came to local ER were seizure-like event. She had noted around 16:00 and 7/19 showed episode of involuntary shaking in her hands bilaterally with symmetric vision loss and urinary incontinence. Patient did say she had seizure-like event in the past secondary to Wellbutrin medication but this was in remote history. Upon arrival to ER, patient afebrile, normotensive. Had troponins which were negative and flat. COVID screen came back positive. Urinalysis bland. EKG with sinus tachycardia. She had CT head negative for any acute intracranial process. Chest x-ray and CTA thorax negative for acute intrathoracic process. Patient was satting above 90% on room air. She was admitted to the hospital observation status for EEG and MRI per neuro request. Patient's EEG came back showing no evidence of epilepsy. MRI brain came back showing no evidence of any acute abnormality. Patient said she was still having some upper chest congestion she thinks related to COVID diagnosis. Repeat chest x-ray day of discharge was negative for any acute abnormalities. For duration of stay patient was not hypoxic. Did prescribe patient albuterol inhaler and Tessalon Perles. Patient inquired about Paxlovid medications for COVID. Discussed with inpatient pharmacy and we do offer Paxlovid inpatient. Patient can follow-up with her PCP to get this medication at discharge as outpatient for COVID. Neurology discussed with patient seizure precautions for discharge including: "no showering/bathing alone, operation of heavy machinery, use of ladders and driving for 6 months seizure free. Patient agreed with plan and verbalized understanding."Did reach out to Neurology and per Neurology no need for neuro follow-up at this time. Discharge stable condition.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Seizure
Hospital-Tage
2,0
Labordaten
-
Aktuelle Erkrankungen
None
Vorgeschichte
Bipolar disorder (HCC) Pure hypercholesterolemia Anemia, unspecified Abnormal Pap smear Subglottic stenosis Thyroid nodule Non-toxic multinodular goiter Schizophrenia (HCC) Shortness of breath Hypertension, benign Type 2 diabetes mellitus without complication (HCC) Abnormal involuntary movement Tardive syndrome Hashimoto's thyroiditis Admission for sterilization Seizure-like activity (HCC)
Andere Medikamente
albuterol HFA (PROVENTIL HFA, VENTOLIN HFA, PROAIR HFA) 108 (90 Base) MCG/ACT inhaler atorvastatin (LIPITOR) 20 MG tablet benzonatate (TESSALON) 100 MG capsule citalopram (CELEXA) 40 MG tablet cyclobenzaprine (FLEXERIL) 10 MG tablet du
Allergien
BupropionSeizure Clozaril [Phenothiazines]Palpitations FluoxetinePalpitations GlimepirideNausea and Vomiting GlipizideNausea Only
Vorherige Impfungen
-

VAERS 1951260

GLAXOSMITHKLINE BIOLOGICALS · INFLUENZA (SEASONAL) (FLULAVAL QUADRIVALENT) · Charge ZD3NZ

schwer
Staat
NC
Alter
1,0
Geschlecht
M
Eingang
15.12.2021
Impfdatum
02.12.2021
Beginn
11.12.2021
Tage bis Beginn
9,0
Dosis
1
Route/Site
IM / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja
Febrile convulsion

Symptomtext

Febrile seizure nine days after administration of vaccines, evaluated in ED, possible AOM at the time, started antibiotics. Fever did not return and was 102 the day of the ED visit.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Febrile convulsion
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
Eggs, nickel, benzyl alcohol, benzoate 4, peanuts, sesquiterpene lactones.
Vorherige Impfungen
-

VAERS 1872923

GLAXOSMITHKLINE BIOLOGICALS · INFLUENZA (SEASONAL) (FLULAVAL QUADRIVALENT) · Charge zd3nz

moderat
Staat
DC
Alter
28,0
Geschlecht
F
Eingang
16.11.2021
Impfdatum
16.11.2021
Beginn
16.11.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Dyspnoea Flushing

Symptomtext

Become Short of breath, flushed within 5 min of getting

Weitere VAERSDATA-Felder
Praegender Schweregrund
Dyspnoea
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Viral few weeks ago
Vorgeschichte
None known
Andere Medikamente
unknown
Allergien
Presumed PCN
Vorherige Impfungen
-

VAERS 1876185

GLAXOSMITHKLINE BIOLOGICALS · INFLUENZA (SEASONAL) (FLULAVAL QUADRIVALENT) · Charge zd3nz

mild
Staat
PA
Alter
30,0
Geschlecht
F
Eingang
17.11.2021
Impfdatum
14.10.2021
Beginn
15.11.2021
Tage bis Beginn
32,0
Dosis
1
Route/Site
- / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Asthenia Joint range of motion decreased Pain Tenderness

Symptomtext

Patient was administered the flu vaccine in the left arm. The next day experienced localized soreness, pain to palpation, limited range of motion, and strength limited by pain. Symptoms have been ongoing to date 11/17/2021

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pain
Hospital-Tage
-
Labordaten
11/15/21 - Urgent care visit
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
None
Allergien
None
Vorherige Impfungen
-

VAERS 2489399

GLAXOSMITHKLINE BIOLOGICALS · INFLUENZA (SEASONAL) (FLULAVAL QUADRIVALENT) · Charge ZD3NZ

gering
Staat
IL
Alter
-
Geschlecht
U
Eingang
26.10.2022
Impfdatum
-
Beginn
-
Tage bis Beginn
-
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered

Symptomtext

Expired FluLaval administered; This case was reported by a nurse via call center representative and described the occurrence of expired vaccine used in a specified number of patients who received Flu Seasonal QIV Quebec (FluLaval Quadrivalent 2021-2022 season) (batch number ZD3NZ, expiry date 30th June 2022) for prophylaxis. Co-suspect products included flu seasonal qiv quebec pre-filled syringe device (Flulaval Tetra Pre-Filled Syringe Device) injection syringe for prophylaxis. On an unknown date, the patient received FluLaval Quadrivalent 2021-2022 season and Flulaval Tetra Pre-Filled Syringe Device. On an unknown date, unknown after receiving FluLaval Quadrivalent 2021-2022 season and Flulaval Tetra Pre-Filled Syringe Device, the patient experienced expired vaccine used. On an unknown date, the outcome of the expired vaccine used was unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK receipt date: 17-Oct-2022 Reporter's comment: The nurse reported that upto 5 patients might had received an expired dose of Flulaval from the 2021-2022 season. The vaccine administration facility was the same as primary reporter. The reporter said follow-up was ok via email above in reporter's details, she was not sure she could give out any patient information and she was still not sure about what patients might had gotten expired doses. The reporter consented to follow-up. Additional supportive information: The patients received an expired of Flulaval, which led to expired vaccine used.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2290715

GLAXOSMITHKLINE BIOLOGICALS · INFLUENZA (SEASONAL) (FLULAVAL QUADRIVALENT) · Charge ZD3Nz

gering
Staat
MI
Alter
56,0
Geschlecht
M
Eingang
23.05.2022
Impfdatum
23.05.2022
Beginn
23.05.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Extra dose administered

Symptomtext

Patient was vaccinated already this flu season. Received a flu vaccine today, but also received a flu vaccine 10/22/21

Weitere VAERSDATA-Felder
Praegender Schweregrund
Extra dose administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2182345

GLAXOSMITHKLINE BIOLOGICALS · INFLUENZA (SEASONAL) (FLULAVAL QUADRIVALENT) · Charge ZD3NZ

gering
Staat
MI
Alter
69,0
Geschlecht
M
Eingang
16.03.2022
Impfdatum
16.03.2022
Beginn
16.03.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Product storage error

Symptomtext

Patient came into the office for a routine visit on 3/16/22. At 929AM on 3/16/22 patient received a flu vaccine and Pfizer Covid-19 vaccine in the left deltoid. Covid-19 vaccine was opened on 1050AM on 3/15/22, and was drawn from vial for vaccine at 929AM on 3/16/22. Upon discovery of mistake made at 1100AM by CMA, RMA report mistake to nurse supervisor, whom then contacted patient to inform them of the incident. RMA contacted Pfizer for medical concerns who stated based of previous studies for the stability of the Pfizer vaccine, the vaccine is safe during the 24 hour timeframe after opening and provider discretion is advised before any rulings are made. Per PA-C, whom patient had seen for their routine visit on 3/16/22, it was cleared patient does not need to receive another Pfizer Covid-19 dose following the incident. RN was made aware of such, and patient was informed as well.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product storage error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
carotid artery disease, tobacco abuse.
Vorgeschichte
carotid artery disease, tobacco abuse.
Andere Medikamente
albuterol sulfate HFA 90 mcg/actuation aerosol inhaler- inhale 2 puff by inhalation route every 4 - 6 hours as needed for shortness of breath, aspirin 81 mg chewable tablet- chew 1 tablet by oral route every day as needed, atorvastatin 40 m
Allergien
No known drug allergies
Vorherige Impfungen
-

VAERS 1954954

GLAXOSMITHKLINE BIOLOGICALS · INFLUENZA (SEASONAL) (FLULAVAL QUADRIVALENT) · Charge ZD3NZ

gering
Staat
WV
Alter
60,0
Geschlecht
F
Eingang
16.12.2021
Impfdatum
10.12.2021
Beginn
10.12.2021
Tage bis Beginn
0,0
Dosis
N/A
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Expired product administered

Symptomtext

None, COVID19 (Pfizer-BioNTech) given out side expiration date.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1927671

GLAXOSMITHKLINE BIOLOGICALS · INFLUENZA (SEASONAL) (FLULAVAL QUADRIVALENT) · Charge ZD3NZ

gering
Staat
VA
Alter
94,0
Geschlecht
M
Eingang
07.12.2021
Impfdatum
01.12.2021
Beginn
01.12.2021
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
SYR / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Incorrect route of product administration

Symptomtext

This case was reported by a pharmacist via call center representative and described the occurrence of intramuscular formulation administered by other route in a 94-year-old male patient who received Flu Seasonal QIV Quebec (FluLaval Quadrivalent 2021-2022 season) (batch number ZD3NZ, expiry date 30th June 2022) for prophylaxis. Co-suspect products included flu seasonal qiv quebec pre-filled syringe device (Flulaval Tetra Pre-Filled Syringe Device) injection syringe for prophylaxis. On 1st December 2021, the patient received FluLaval Quadrivalent 2021-2022 season (intravenous) and Flulaval Tetra Pre-Filled Syringe Device. On 1st December 2021, unknown after receiving FluLaval Quadrivalent 2021-2022 season and Flulaval Tetra Pre-Filled Syringe Device, the patient experienced intramuscular formulation administered by other route. On an unknown date, the outcome of the intramuscular formulation administered by other route was unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional details were provided as follows: The patient received FluLaval Quadrivalent via Intravenous route, which led to intramuscular formulation administered by other route. The reporter consented to follow up.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Incorrect route of product administration
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-